Brief: Integra Lifesciences Q1 Adjusted EPS USD 0.55 Vs. IBES Estimate USD 0.55
06/05/2024 11:00
May 06 (Reuters) - Integra Lifesciences Q1 adjusted EBITDA USD 71.8 million vs. IBES estimate USD 71.9 million. * Q1 adjusted net income USD 43 million vs. IBES estimate USD 43.2 million * Q1 revenue USD 368.9 million vs. IBES estimate USD 362 million * Q1 adjusted gross margin 64.4% * outlook FY revenue USD 1,672-1,687 million
Recent news on Integra LifeSciences Holdings
See all newsIntegra LifeSciences Holdings Corporation reports results for the quarter ended September 30 - Earnings Summary
Integra Lifesciences Q3 revenue slightly misses estimates on flood damage
Brief: Integra Lifesciences - Enters Amended And Restated Credit Agreement On Oct 19, 2026 - SEC Filing
Brief: Integra Announces Completion Of Refinancing Transactions
Brief: Integra Announces Pricing Of Senior Secured Notes